The report "Hemostats Market by Product Type (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), and Geography (Americas, Europe, APAC, MEA) - Global Forecast to 2020", The global hemostats market size is anticipated to reach USD 2.76 Billion by 2020, at a CAGR of 6.2% from 2015 to 2020. Factors such as increasing surgical procedures and rising number of insurance providers are driving the hemostats market. According to Center for Disease Control and Prevention (CDC), 51.4 Million surgeries have taken place in the U.S. in 2014. The increase in number of surgeries accelerates the demand for hemostats and thereby is driving the growth of the market. However, the high cost of products hinder the growth of the global hemostats market.
Browse 199 market data Tables and 90 Figures spread through 159 Pages and in-depth TOC on "Hemostats Market
Early buyers will receive 10% customization on this report.
Based on product type, the global hemostats market is segmented into thrombin-based, oxidized regenerated cellulose based hemostats, combination hemostats, gelatin based hemostats, and collagen based hemostats. The thrombin based hemostats segment dominates the hemostats market and is projected to grow at a significant pace during the forecast period, in terms of value.
Based on geography, the global hemostat market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. Each region is further segmented into countries, covering around 50 countries, globally. The market in the Americas is one of the key geographical segments that generates major revenue in the global hemostats market. The growth in the Americas hemostats market is attributed to the increase in number of surgical procedures. However, the hemostats market in Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period. Increasing healthcare infrastructure along with rise in number of surgeries are propelling the growth of this market.
Talk to Our Research Analysts for More Info@
Major companies operational in the hemostats market are Johnson & Johnson Services, Inc. (U.S.). C. R. Bard, Inc. (U.S.), Baxter (U.S.), B Braun Melsungen AG (Germany), Pfizer Inc. (U.S.), Vascular Solutions, Inc. (U.S.), Gelita Medical GmbH (Germany), Equimedical (Netherlands), Integra Lifesciences Holdings Corporation (U.S.), Z-Medica, LLC (U.S.), and Marine Polymer Technologies, Inc. (U.S.).
Get The Sample Copy Of This Report:
The research study is aimed at identifying emerging trends and opportunities in the global hemostats market along with detailed classifications, in terms of revenue. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global hemostats market on the basis of product type and geography. Apart from the market segmentation, this report also provides an in-depth analysis of the market by providing a detailed process flow diagram and market dynamics, such as drivers, restraints, and opportunities in the global hemostats market.
Browse Related Reports:
Coagulation/Hemostasis Analyzer Market by Product (Automated, POC), Consumables (Reagents, Standards), Test Type (APTT, Prothrombin Time/INR, D-Dimer, Fibrinogen), Technology (Mechanical, Optical), End Users (Research Institutes, Hospitals) - Forecast to 2019.
Biosurgery Market by Type (Surgical Sealants, Hemostatic Agents, Soft Tissue Attachments, Adhesion Barriers, Bone Graft Substitutes), Application (Neurological, Cardiovascular, General, Orthopedic, Reconstructive) - Global Forecast to 2020.
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets